DRRX

DRRX

USD

DURECT Corporation Common Stock

$0.660+0.062 (10.392%)

Prix en Temps Réel

Healthcare
Drug Manufacturers - Specialty & Generic
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$0.598

Haut

$0.680

Bas

$0.598

Volume

0.06M

Fondamentaux de l'Entreprise

Capitalisation Boursière

20.5M

Industrie

Drug Manufacturers - Specialty & Generic

Pays

United States

Statistiques de Trading

Volume Moyen

0.11M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.48Actuel $0.660Haut $1.84

Actualités Connexes

Analyst Upgrades

HC Wainwright & Co. Reiterates Neutral on Durectto Neutral

HC Wainwright & Co. analyst Ed Arce reiterates Durect from Neutral to Neutral.

Voir plus
HC Wainwright & Co. Reiterates Neutral on Durectto Neutral
PR Newswire

DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the fourth quarter and full year ended December 31, 2024 and provided a...

Voir plus
DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
PR Newswire

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update

DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated ...

Voir plus
DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.